Telemedicine programs for managing cystic fibrosis (CF) were at least as effective as standard in-clinic care, according to a…
Articles by Steve Bryson, PhD
LasB, an enzyme that promotes Pseudomonas aeruginosa infections in the lungs of people with cystic fibrosis (CF), is…
A newly identified therapeutic target showed a potential to enhance the effectiveness of antibiotics against resistant Mycobacterium abscessus (Mabs) lung…
The U.S. Food and Drug Administration (FDA) will allow children with cystic fibrosis (CF) as young as age 2…
Children and adolescents who are wait-listed for lung transplantation and have the worst functional status are at the greatest risk…
CFTR modulator therapies can enhance the ability of certain immune cells to kill bacteria, independent of defects in the CFTR…
A Chicago children’s hospital is leading an awareness campaign to reduce the missed or delayed diagnosis of cystic fibrosis…
One year of treatment with hypertonic saline, inhaled twice daily, reduced the thickness of the airway walls in children…
People with cystic fibrosis (CF) who were underweight before treatment gained the most weight after six months on…
Trikafta treatment for six months in people with cystic fibrosis (CF) was found in a real-world study to…